jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Aluminium Serum

Kidney
image

Report in 96Hrs

image

At Home

nofastingrequire

No Fasting Required

Details

Measures aluminium concentration in blood.

2,7383,911

30% OFF

Aluminium Serum Test Information Guide

  • Why is it done?
    • Measures the concentration of aluminium in blood serum to assess aluminium accumulation and toxicity in the body
    • Monitors patients with chronic kidney disease or those undergoing hemodialysis, as aluminium accumulates when renal clearance is impaired
    • Assesses for aluminium-related bone disease and neurotoxicity complications
    • Evaluates occupational or environmental aluminium exposure in at-risk workers
    • Investigates symptoms of aluminium toxicity such as bone pain, weakness, or neurological changes
    • Typically performed routinely in patients on long-term dialysis and when clinical symptoms suggest aluminium toxicity
  • Normal Range
    • Normal Reference Range: 0-10 mcg/L (micrograms per liter) or 0-0.37 mcmol/L (micromoles per liter)
    • Units of Measurement: mcg/L (micrograms per liter) or mcmol/L (micromoles per liter)
    • Borderline Elevated: 10-20 mcg/L - may warrant monitoring and investigation
    • Elevated: >20 mcg/L - indicative of aluminium accumulation and potential toxicity
    • Interpretation: Normal results indicate adequate aluminium clearance and no significant accumulation. Elevated levels suggest impaired elimination, increased exposure, or potential aluminium toxicity requiring further investigation and intervention.
  • Interpretation
    • Normal Results (0-10 mcg/L): Indicates normal aluminium levels with adequate renal clearance; no clinical concern for aluminium toxicity
    • Slightly Elevated (10-20 mcg/L): Suggests mild aluminium accumulation; warrants increased monitoring and dietary restrictions; may indicate early stages of impaired clearance
    • Moderately Elevated (20-50 mcg/L): Indicates significant aluminium accumulation with potential risk of toxicity; requires investigation of exposure sources and management of underlying renal disease
    • Highly Elevated (>50 mcg/L): Indicates substantial aluminium toxicity with high risk of aluminium-related bone disease, neurological complications, and microcytic anaemia; urgent intervention needed
    • Factors Affecting Results: Degree of renal function, dialysis efficiency, use of aluminium-containing medications (phosphate binders, antacids), occupational exposure, tap water content used in dialysate, dietary aluminium intake, and duration of chronic kidney disease
    • Clinical Significance: Elevated aluminium levels are critical markers of potential organ toxicity, particularly affecting bone metabolism (causing osteodystrophy), neurological function (causing dementia and encephalopathy), and hematopoiesis (microcytic anaemia); serial measurements help track accumulation trends
  • Associated Organs
    • Primary Organ Systems: Kidneys (primary route of aluminium elimination), bones (target organ for toxicity), brain and nervous system (neurological complications), and blood-forming tissues (bone marrow)
    • Associated Conditions and Complications:
      • Chronic kidney disease (CKD) and end-stage renal disease (ESRD)
      • Aluminium-related bone disease (adynamic bone disease, osteodystrophy)
      • Dialysis encephalopathy syndrome (progressive neurological deterioration)
      • Microcytic anaemia (impaired erythropoiesis)
      • Dementia and cognitive impairment
      • Occupational aluminium exposure-related pulmonary and neurological disease
      • Secondary hyperparathyroidism complications
    • Potential Complications from Elevated Levels: Bone pain and fractures, seizures and encephalopathy, progressive cognitive decline, muscle weakness, growth retardation in children, impaired immune function, and increased cardiovascular mortality risk in dialysis patients
  • Follow-up Tests
    • Based on Elevated Results:
      • Repeat serum aluminium measurement (within 2-4 weeks) to confirm elevation and track trends
      • Deferoxamine challenge test (DFO test) to assess body aluminium burden and predict risk of aluminium-related bone disease
      • Bone markers (alkaline phosphatase, parathyroid hormone) and bone biopsy if aluminium osteodystrophy suspected
      • Serum calcium and phosphorus levels to assess mineral metabolism
      • Parathyroid hormone (PTH) levels for secondary hyperparathyroidism assessment
      • Renal function tests (creatinine, urea, eGFR) to evaluate kidney function status
      • Complete blood count (CBC) to assess for microcytic anaemia
      • Bone mineral density (DEXA scan) if osteoporosis or bone disease suspected
      • Neuropsychological testing if cognitive or neurological symptoms present
    • Monitoring Frequency: For dialysis patients: baseline test, then annually or semi-annually for stable patients; monthly or more frequently if elevated; for non-dialysis patients with occupational exposure or symptoms: baseline and as clinically indicated
    • Complementary Information Tests: Iron studies (ferritin, iron saturation), magnesium and other trace elements, urinalysis, and imaging studies (skeletal surveys, CT) as indicated by clinical presentation
  • Fasting Required?
    • Fasting Requirement: No - fasting is not required for serum aluminium testing
    • Sample Collection: Blood drawn via venipuncture into standard collection tubes (typically serum separator tube); can be collected at any time of day
    • Medications to Avoid: No medications need to be discontinued; however, inform healthcare provider of all current medications including aluminium-containing antacids or phosphate binders as these may affect test interpretation
    • Patient Preparation:
      • No special preparation needed; routine blood draw procedures apply
      • Wear comfortable clothing with accessible arm for blood collection
      • Remain well-hydrated before the test
      • For dialysis patients: test may be scheduled before or after dialysis session; timing consistency is important for trend assessment
      • Inform phlebotomist of concerns regarding aluminum exposure or symptoms
    • Important Considerations: Laboratory must use aluminium-free collection tubes and equipment to prevent contamination; results should be reported promptly; serial measurements taken at consistent times enhance reliability of trend interpretation

How our test process works!

customers
customers